We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Evaluating Textbook Outcome as a Robust Quality Metric for Hospital Benchmarking in Adult Cardiac Surgery
Cardiologytextbook outcomeCardiac surgery quality

Evaluating Textbook Outcome as a Robust Quality Metric for Hospital Benchmarking in Adult Cardiac Surgery

By MedXY|Aug 23, 2026

Textbook outcome—a composite measure of survival without complications or prolonged hospitalization—effectively distinguishes hospital performance and predicts 180-day mortality and readmission following elective adult cardiac surgery.

Beyond Stenosis: How Carotid Plaque Calcification Patterns on CTA Predict Stroke Risk
CardiologyCarotid artery diseaseStroke risk stratification

Beyond Stenosis: How Carotid Plaque Calcification Patterns on CTA Predict Stroke Risk

By MedXY|Aug 22, 2026

This study reveals that the characteristics of carotid plaque calcifications on CTA scans correlate with stroke symptoms beyond traditional stenosis severity, offering improved risk stratification for carotid artery disease.

Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries
CardiologyPhục hồi chức năng timGuideline therapy

Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries

By MedXY|Aug 22, 2026

This article reviews improvements in heart failure management and outcomes in Japan between 2013 and 2019-21, highlighting increased guideline-based therapy use and enhanced post-discharge care leading to reduced mortality and readmission r

Unveiling the Role of Myeloid Cells in Right Ventricular Dysfunction in HFpEF via Sterile Inflammation
CardiologyHFpEFmyeloid cells

Unveiling the Role of Myeloid Cells in Right Ventricular Dysfunction in HFpEF via Sterile Inflammation

By MedXY|Aug 22, 2026

This article explores how myeloid cell expansion drives right ventricular dysfunction in HFpEF through sterile inflammation, highlighting translational insights from murine models and human studies.

Bempedoic Acid Significantly Reduces Limb and Cardiovascular Events in Statin-Intolerant Patients with Peripheral Artery Disease: Insights from the CLEAR Outcomes Trial
Cardiologymajor adverse limb eventstatin intolerance

Bempedoic Acid Significantly Reduces Limb and Cardiovascular Events in Statin-Intolerant Patients with Peripheral Artery Disease: Insights from the CLEAR Outcomes Trial

By MedXY|Aug 22, 2026

Bempedoic acid reduces the risk of major adverse limb and cardiovascular events in statin-intolerant patients with peripheral artery disease, illustrating its potential to enhance vascular risk management.

Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics
Allergy & Immunologycardiovascular diseaserisk stratification

Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics

By MedXY|Aug 21, 2026

Single-cell multi-omics profiling reveals novel immune signatures linked to coronary artery disease and cardiovascular outcomes, independent of traditional inflammatory markers, offering new avenues for risk stratification and personalized

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial
CardiologydiabetesHFpEF

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial

By MedXY|Aug 21, 2026

The TARTAN-HF trial demonstrated that targeted natriuretic peptide screening in high-risk diabetic patients uncovers a high prevalence of undiagnosed heart failure, mainly HFpEF, enabling earlier treatment initiation and improved clinical c

AI-ECG for Detecting Structural Heart Disease in the Community: Evaluating Real-World Applicability in the PREVUE-VALVE Study
AIcommunity health结构性心脏病

AI-ECG for Detecting Structural Heart Disease in the Community: Evaluating Real-World Applicability in the PREVUE-VALVE Study

By MedXY|Aug 21, 2026

The PREVUE-VALVE Study demonstrates that AI-ECG models developed in hospital settings show reduced diagnostic accuracy when applied to community populations with lower disease prevalence and milder structural heart disease, underscoring the

Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT Trial
Cardiologycardiovascular diseaseobesity

Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT Trial

By MedXY|Aug 21, 2026

In the SELECT trial, semaglutide significantly lowered hsCRP levels and major cardiovascular events in patients with established atherosclerotic cardiovascular disease and overweight or obesity, suggesting inflammation reduction as a possib

Metrnl: A Novel Inhibitor of Platelet Activation Targeting CD36 to Mitigate Thrombosis and Acute Myocardial Injury
CardiologyCD36 receptorMetrnl

Metrnl: A Novel Inhibitor of Platelet Activation Targeting CD36 to Mitigate Thrombosis and Acute Myocardial Injury

By MedXY|Aug 21, 2026

Metrnl reduces platelet activation and thrombus formation by promoting CD36 degradation, offering a promising therapeutic strategy for thrombotic diseases including acute myocardial infarction without increasing bleeding risk.

suPAR as a Novel Marker for Residual Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes with Coronary Artery Disease
Cardiologycoronary artery diseasehs-CRP

suPAR as a Novel Marker for Residual Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes with Coronary Artery Disease

By MedXY|Aug 21, 2026

In type 2 diabetes patients with coronary artery disease, suPAR levels remain unchanged despite treatment and independently predict adverse cardiovascular events beyond hs-CRP, highlighting suPAR’s potential in identifying treatment-r

Left Atrial Dysfunction and Vutrisiran Efficacy in Transthyretin Amyloid Cardiomyopathy: Insights from the HELIOS-B Trial
Cardiologyleft atrial dysfunctioncardiomyopathy

Left Atrial Dysfunction and Vutrisiran Efficacy in Transthyretin Amyloid Cardiomyopathy: Insights from the HELIOS-B Trial

By MedXY|Aug 21, 2026

This article reviews the prognostic role of left atrial dysfunction in transthyretin amyloid cardiomyopathy and evaluates vutrisiran’s impact on atrial function and clinical outcomes based on a secondary analysis of the HELIOS-B phase 3 tri

RUNX1-Driven Endothelial-to-Mesenchymal Transition: A Novel Mechanistic Link and Therapeutic Target in LMNA Cardiomyopathy
CardiologyLMNA cardiomyopathyRUNX1

RUNX1-Driven Endothelial-to-Mesenchymal Transition: A Novel Mechanistic Link and Therapeutic Target in LMNA Cardiomyopathy

By MedXY|Aug 21, 2026

This study identifies RUNX1-mediated endothelial-to-mesenchymal transition as a key driver of myocardial fibrosis and remodeling in LMNA cardiomyopathy, highlighting potential therapeutic avenues targeting endothelial RUNX1 signaling.

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications
Cardiologycardiovascular eventsstroke prevention

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications

By MedXY|Aug 21, 2026

This review synthesizes evidence on colchicine’s efficacy in secondary stroke prevention, emphasizing the impact of concomitant atherosclerosis on outcomes from the CONVINCE trial and meta-analyses.

Optimizing LDL-C Reduction Strategies in Ischemic Stroke: Impact of Achieving ≥50% LDL-C Reduction from Baseline
CardiologyLDL-C reductioncardiovascular risk

Optimizing LDL-C Reduction Strategies in Ischemic Stroke: Impact of Achieving ≥50% LDL-C Reduction from Baseline

By MedXY|Aug 21, 2026

Achieving a ≥50% reduction in LDL-C from baseline independently reduces recurrent cardiovascular events post-ischemic stroke, suggesting that combining relative and absolute LDL-C targets improves long-term outcomes.

Video Games and Human Health: A Narrative Review With Special Emphasis on Active and Motion-Controlled Video Games
CardiologyVideo Games

Video Games and Human Health: A Narrative Review With Special Emphasis on Active and Motion-Controlled Video Games

By MedXY|Aug 21, 2026

MedXY editors Abstract Video gaming should not be treated as a single health exposure. Conventional sedentary video games, cognitively oriented games,

Longitudinal Heart Stress Changes and Cardiovascular Risk in Older Adults: Insights from NT-proBNP Dynamics
Cardiologycardiovascular diseaseolder adults

Longitudinal Heart Stress Changes and Cardiovascular Risk in Older Adults: Insights from NT-proBNP Dynamics

By MedXY|Aug 20, 2026

Changes in NT-proBNP levels over three years define heart stress status, which improves cardiovascular and mortality risk prediction in older adults without prior CVD, underscoring its utility in clinical risk stratification.

Declining Use But Persistent Readmissions: A National Analysis of Open Lower Extremity Revascularization Outcomes
CardiologyChronic Limb-Threatening IschemiaPeripheral Artery Disease

Declining Use But Persistent Readmissions: A National Analysis of Open Lower Extremity Revascularization Outcomes

By MedXY|Aug 19, 2026

This national study identifies key factors linked to 30-day nonelective readmissions after open lower extremity revascularization, highlighting stable readmission rates despite reduced procedure volume and the need for standardized discharg

Gout as a Modifiable Risk Factor for Ischemic Stroke in Atrial Fibrillation: Insights from the FinACAF Study
Cardiologyurate-lowering therapyischemic stroke

Gout as a Modifiable Risk Factor for Ischemic Stroke in Atrial Fibrillation: Insights from the FinACAF Study

By MedXY|Aug 19, 2026

This nationwide Finnish cohort study reveals that gout increases ischemic stroke risk in atrial fibrillation patients, with urate-lowering therapy linked to reduced stroke incidence, underscoring gout’s potential role in stroke risk s

Finerenone Efficacy in Cardio-Kidney-Metabolic Syndrome Patients With or Without History of Cancer: Insights from the FINE-HEART Analysis
CardiologyfinerenoneCancer Comorbidity

Finerenone Efficacy in Cardio-Kidney-Metabolic Syndrome Patients With or Without History of Cancer: Insights from the FINE-HEART Analysis

By MedXY|Aug 19, 2026

Finerenone reduces mortality, cardiovascular, and kidney complications in cardio-kidney-metabolic syndrome patients regardless of cancer history, while patients with cancer experience greater disease burden and adverse events.

Prev
9 / 25
1…7891011…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles